159 related articles for article (PubMed ID: 12452542)
21. Hypothalamic-pituitary-adrenal and -thyroid axis dysfunctions and decrements in the availability of L-tryptophan as biological markers of suicidal ideation in major depressed females.
Maes M; Vandewoude M; Schotte C; Martin M; Blockx P; Scharpe S; Cosyns P
Acta Psychiatr Scand; 1989 Jul; 80(1):13-7. PubMed ID: 2548371
[TBL] [Abstract][Full Text] [Related]
22. ECT use in unipolar and bipolar depression.
Agarkar S; Hurt S; Lisanby S; Young RC
J ECT; 2012 Sep; 28(3):e39-40. PubMed ID: 22914639
[TBL] [Abstract][Full Text] [Related]
23. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
[TBL] [Abstract][Full Text] [Related]
24. [Thyroid function in depressed patients].
De Mendonça Lima CA; Vandel S; Bonin B; Bertschy G; Bizouard P
Encephale; 1996; 22(2):85-94. PubMed ID: 8706626
[TBL] [Abstract][Full Text] [Related]
25. Hypothalamic-pituitary-end organ function in women with bipolar depression.
Rasgon NL; Kenna HA; Wong ML; Whybrow PC; Bauer M
Psychoneuroendocrinology; 2007 Apr; 32(3):279-86. PubMed ID: 17317022
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of ECT in major depressive disorders: a neuroendocrine interpretation.
Nerozzi D; Graziosi S; Melia E; Aceti F; Magnani A; Fiume S; Fraioli F; Frajese G
Psychiatry Res; 1987 Mar; 20(3):207-13. PubMed ID: 3108918
[TBL] [Abstract][Full Text] [Related]
27. Response to ECT in bipolar I, bipolar II and unipolar depression.
Medda P; Perugi G; Zanello S; Ciuffa M; Cassano GB
J Affect Disord; 2009 Nov; 118(1-3):55-9. PubMed ID: 19223079
[TBL] [Abstract][Full Text] [Related]
28. Thyroxine binding and TSH in recurrent depressive episodes.
Tollefson G; Valentine R; Hoffmann N; Garvey MJ; Tuason VB
J Clin Psychiatry; 1985 Jul; 46(7):267-72. PubMed ID: 3891744
[TBL] [Abstract][Full Text] [Related]
29. Electric stimulus energy and the clinical response to electroconvulsive therapy.
Bean GJ; Marchese V; Martin BA
Can J Psychiatry; 1991 Nov; 36(9):637-44. PubMed ID: 1773399
[TBL] [Abstract][Full Text] [Related]
30. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
Sarandöl A; Taneli B; Sivrioğlu Y
Turk Psikiyatri Derg; 2003; 14(2):116-24. PubMed ID: 12844278
[TBL] [Abstract][Full Text] [Related]
31. Hypothalamic--pituitary--adrenal axis and monoamine transmitter activity in depression: a pilot study of central and peripheral effects of electroconvulsive therapy.
Rudorfer MV; Risby ED; Osman OT; Gold PW; Potter WZ
Biol Psychiatry; 1991 Feb; 29(3):253-64. PubMed ID: 1707686
[TBL] [Abstract][Full Text] [Related]
32. Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella.
Cannavò S; Curtò L; Venturino M; Squadrito S; Almoto B; Narbone MC; Rao R; Trimarchi F
J Endocrinol Invest; 2002 Mar; 25(3):236-9. PubMed ID: 11936465
[TBL] [Abstract][Full Text] [Related]
33. Superior anti-suicidal effects of electroconvulsive therapy in unipolar disorder and bipolar depression.
Liang CS; Chung CH; Ho PS; Tsai CK; Chien WC
Bipolar Disord; 2018 Sep; 20(6):539-546. PubMed ID: 29227012
[TBL] [Abstract][Full Text] [Related]
34. Clinical and neuroendocrine features of endogenous unipolar and bipolar depression.
Gurpegui M; Casanova J; Cervera S
Acta Psychiatr Scand Suppl; 1985; 320():30-7. PubMed ID: 3863467
[TBL] [Abstract][Full Text] [Related]
35. Remission of symptoms in patients with unipolar and bipolar depression submitted to electroconvulsive therapy.
Antunes PB; Fleck MP
J ECT; 2009 Dec; 25(4):291. PubMed ID: 19956019
[No Abstract] [Full Text] [Related]
36. Changes in hypothalamic-pituitary-thyroid axis following successful treatment with low-frequency right prefrontal transcranial magnetic stimulation in treatment-resistant depression.
Kito S; Hasegawa T; Fujita K; Koga Y
Psychiatry Res; 2010 Jan; 175(1-2):74-7. PubMed ID: 20004482
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
[TBL] [Abstract][Full Text] [Related]
38. The hypothalamic-pituitary-thyroid axis in agoraphobia, panic disorder, major depression and normal controls.
Hofmann PJ; Nutzinger DO; Kotter MR; Herzog G
J Affect Disord; 2001 Sep; 66(1):75-7. PubMed ID: 11532535
[TBL] [Abstract][Full Text] [Related]
39. Effects of ECT course on TSH and prolactin responses to TRH in depressed patients.
Lykouras L; Markianos M; Hatzimanolis J; Stefanis C
J Affect Disord; 1991 Dec; 23(4):191-7. PubMed ID: 1791264
[TBL] [Abstract][Full Text] [Related]
40. Acute and prolonged effects of insulin-induced hypoglycemia on the pituitary-thyroid axis in humans.
Schultes B; Oltmanns KM; Kern W; Born J; Fehm HL; Peters A
Metabolism; 2002 Oct; 51(10):1370-4. PubMed ID: 12370861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
